These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9934945)
1. An open trial of olanzapine in patients with treatment-refractory psychoses. Sanders RD; Mossman D J Clin Psychopharmacol; 1999 Feb; 19(1):62-6. PubMed ID: 9934945 [TBL] [Abstract][Full Text] [Related]
2. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603 [TBL] [Abstract][Full Text] [Related]
4. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study. Madhusoodanan S; Brenner R; Suresh P; Concepcion NM; Florita CD; Menon G; Kaur A; Nunez G; Reddy H Ann Clin Psychiatry; 2000 Mar; 12(1):11-8. PubMed ID: 10798821 [TBL] [Abstract][Full Text] [Related]
6. Olanzapine: an updated review of its use in the management of schizophrenia. Bhana N; Foster RH; Olney R; Plosker GL Drugs; 2001; 61(1):111-61. PubMed ID: 11217867 [TBL] [Abstract][Full Text] [Related]
7. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine. Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736 [TBL] [Abstract][Full Text] [Related]
8. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192 [TBL] [Abstract][Full Text] [Related]
9. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575 [TBL] [Abstract][Full Text] [Related]
10. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia. Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder. Harvey PD; Napolitano JA; Mao L; Gharabawi G Int J Geriatr Psychiatry; 2003 Sep; 18(9):820-9. PubMed ID: 12949850 [TBL] [Abstract][Full Text] [Related]
12. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients. Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139 [TBL] [Abstract][Full Text] [Related]
13. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Fulton B; Goa KL Drugs; 1997 Feb; 53(2):281-98. PubMed ID: 9028746 [TBL] [Abstract][Full Text] [Related]
14. The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric hospital. Parepally H; Chakravorty S; Levine J; Brar JS; Patel AM; Baird JW; Chalasani L; Delaney JA; Atzert R; Chengappa KN Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):437-40. PubMed ID: 11999892 [TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Conley RR; Mahmoud R Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400 [TBL] [Abstract][Full Text] [Related]
16. Switching clozapine responders to olanzapine. Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595 [TBL] [Abstract][Full Text] [Related]
17. Olanzapine for schizophrenia. Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S Cochrane Database Syst Rev; 2000; (2):CD001359. PubMed ID: 10796640 [TBL] [Abstract][Full Text] [Related]
18. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748 [TBL] [Abstract][Full Text] [Related]
19. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years. Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974 [TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Tran PV; Hamilton SH; Kuntz AJ; Potvin JH; Andersen SW; Beasley C; Tollefson GD J Clin Psychopharmacol; 1997 Oct; 17(5):407-18. PubMed ID: 9315992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]